Common MS drugs Taken Together Do Not Reduce Relapse Risk

[MSUK]

Common Multiple Sclerosis Drugs Taken Together Do Not Reduce Relapse Risk

A recent clinical trial found that interferonβ-1a (INF) and glatiramer acetate (GA), two of the most commonly prescribed drugs for multiple sclerosis (MS), provide no additional clinical benefit when taken together. While findings published today in Annals of Neurology, a journal of the American Neurological Association and Child Neurology Society, suggest that taking both INF and GA together was not superior to GA monotherapy in reducing relapse risk; the combination therapy does appear to reduce new lesion activity and total lesion volume..... Read More - http://www.ms-uk.org/index.cfm/MSnews